###begin article-title 0
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 376 379 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC</italic>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 513 520 513 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 603 605 603 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 629 633 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 663 669 663 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 684 688 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 755 762 755 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 847 854 847 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 917 924 917 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 972 976 972 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
A single nucleotide polymorphism (SNP) rs6983267, located within the 8q24 region, is strongly associated with risk of colorectal and prostate cancer. It has been suggested that the mechanism of this association is related to differential interaction of TCF7L2 protein (previously known as TCF-4) with alleles of rs6983267, influencing the expression of a well-known oncogene, MYC, located 335 Kb telomeric. Here, we tested the correlation between mRNA expression of MYC and several alternatively spliced forms of TCF7L2 in 117 non-cancer colon samples. We observed a strong correlation (r = 0.60, p < 10-6) between expression of MYC and a unique splicing form of TCF7L2. The level of MYC expression in these samples was associated with expression of some TCF7L2 splicing forms but not with genotypes of rs6983267, or interaction of rs6983267 with TCF7L2 expression. These findings suggest that some splicing forms of TCF7L2 may be functionally important for regulation of MYC expression in colon tissue but this regulation is not directly dependent on rs6983267.
###end p 2
###begin title 3
Findings
###end title 3
###begin p 4
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 994 996 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1121 1125 1121 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1133 1135 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1263 1267 1263 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1279 1281 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1282 1284 1282 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1287 1291 1287 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1322 1324 1322 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1402 1406 1402 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1416 1418 1416 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1496 1500 1496 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1530 1532 1530 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1533 1535 1533 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1570 1572 1570 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1573 1575 1573 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1576 1578 1576 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1579 1581 1579 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1628 1629 1628 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
Recent genome-wide association studies (GWAS) have identified a single nucleotide polymorphism (SNP) rs6983267 within the 8q24 region associated with increased susceptibility to colorectal and prostate cancer [1-6]. Follow-up association studies have suggested that the same variant may also increase the risk for cancers of the kidney, thyroid and larynx [7,8]. The location of rs6983267 in the intergenic region 335 Kb upstream from the MYC gene, a well-known oncogene [9], generated a hypothesis that this SNP might be involved in a long-distance regulation of MYC expression. Located in a region with significant evolutionary conservation and enhancer potential [10-12], the SNP was predicted to affect a binding site for TCF7L2 [10,11], a key transcription factor in the WNT pathway. The risk allele G of rs6983267 was found to have a slightly stronger affinity to TCF7L2 in binding assays compared to the non-risk allele T, and stronger regulatory activity in luciferase reporter assays [10,11]. An analysis of long-range interactions showed that the region containing rs6983267 might be in physical proximity with MYC region [10]. These findings suggested that rs6983267 might be located within an enhancer element that interacts with TCF7L2 and regulates MYC expression [10,11]. MYC is a target gene of TCF7L2 [13-15] and its expression is regulated through two TCF7L2 binding sites within the MYC promoter [13]. No association has been found between rs6983267 and the mRNA expression of MYC in lymphoblastoid cell lines [11,16], normal and tumor colon samples [10,11,17-20], or with MYC immunostaining in colon tumors [5].
###end p 4
###begin p 5
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 302 309 302 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 496 503 496 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 83 88 <span type="species:ncbi:9606">human</span>
Previously, we performed a detailed study of TCF7L2 expression in several types of human tissue, including colon where we measured the expression of multiple assays targeting the majority of known splicing forms of TCF7L2 [21,22]. In the current study we sought to determine, whether the expression of TCF7L2 splicing forms we identified in non-cancer colon samples correlated with MYC expression and whether this expression was dependent on alleles of rs6983267 or interaction of rs6983267 with TCF7L2 expression.
###end p 5
###begin p 6
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 834 841 834 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 917 918 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 924 926 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
We investigated non-cancer colon samples on the assumption that the effect of a germline genetic variation might be more easily detectable in conditions not affected by the effects of cancer or its treatment. The samples and the methods are described in Additional file 1. The mRNA expression of MYC was detected by sensitive quantitative reverse-transcriptase PCR (qRT-PCR) and 3 expression assays (Figure 1A.) The expression of MYC assays 1 and 2, corresponding to exons 2-3, and 1-2, respectively (RefSeq transcript NM_002467), was highly correlated (r = 0.95). MYC assay 3 targeted an alternative transcript initiated from a promoter P0 (GenBank accession number ) [23], however, expression of this transcript was very low (at a level of at least 100 times lower than of assays 1 and 2) and was not studied further. Expression of TCF7L2 was measured with 7 assays previously described (Figure 1B, Additional file 2) [21,22].
###end p 6
###begin p 7
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Location of <italic>MYC </italic>and <italic>TCF7L2 </italic>expression assays</bold>
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 380 381 380 381 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 405 412 405 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
Location of MYC and TCF7L2 expression assays. A. MYC exons and 5' and 3'untranslated regions (UTRs) are marked by rectangles and two translation starts are marked by vertical lines and arrows. MYC assay1 is located over the junction of exons 2 and 3, and MYC assay 2 is located over the junction of exons 1 and 2. MYC assay 3 targets alternative transcript with an upstream exon. B. Constitutive exons of TCF7L2 are represented as black rectangles and alternative exons as white rectangles. Protein domains are indicated above corresponding exons: beta-catenin binding domain is encoded by exons 1 and 2, high mobility group (HMG) DNA-binding domain is encoded by exons 9 and 10 and the CRARF DNA-binding domain is encoded by exons 13 and 14. Location of expression assays is indicated under corresponding exons and arrows show primer positions. The specificity of detection of particular splicing forms is achieved by probes located over exon junctions.
###end p 7
###begin p 8
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 181 183 181 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 424 431 424 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 822 823 822 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 912 913 912 913 <underline xmlns:xlink="http://www.w3.org/1999/xlink">R</underline>
###xml 1013 1014 1013 1014 <underline xmlns:xlink="http://www.w3.org/1999/xlink">L</underline>
###xml 1024 1025 1024 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1206 1208 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1321 1323 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1324 1326 1324 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1413 1417 1413 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1507 1509 1507 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1510 1512 1510 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1636 1640 1636 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1745 1752 1745 1752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 1774 1776 1774 1776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1777 1779 1777 1779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2139 2141 2139 2141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 2142 2144 2142 2144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 2206 2213 2206 2213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 2217 2221 2217 2221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 2239 2240 2239 2240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 2281 2285 2281 2285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 2401 2408 2401 2408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 2479 2486 2479 2486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 2493 2494 2493 2494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1759 1764 <span type="species:ncbi:9606">human</span>
The strongest correlation between MYC and TCF7L2 expression was observed for assay "ex13-14" of TCF7L2 (r = 0.57- 0.60, p < 10-6), followed by assay "ex11-13" (r = 0.52-0.54, p < 10-6). The weakest correlation was detected for assay "ex11-13a" (r = 0.10 - 0.15, p = 0.12 - 0.28) (Table 1). These assays detect alternative splicing forms that include combinations of exons 11-13-14 and 11-13a-14 in the C-terminal end of the TCF7L2 transcripts (GenBank accession numbers  and ). Both protein isoforms encoded by these splicing forms have long C-terminal reading frames (E-tails) with binding sites for the C-terminal binding protein (CtBP) involved in post-translational regulation of TCF7L2 expression [21,22]. Protein fragments encoded by the alternative exons 13 and 13a share 68% identity (17 amino acids of 25, Figure 2). The form with exons 11-13-14 encodes a 30-amino-acid highly conserved motif with a CRARF signature protein sequence, while in the form with exons 11-13a-14 this sequence is changed to CRALF (Figure 2). The CRARF protein sequence is also found in another member of TCF/LEF family of transcription factors, TCF-7 (former TCF-1) and in the ancestral drosophila TCF/pangolin protein [24]. The CRARF sequence serves as an additional DNA-binding domain and a strong transactivator of the WNT pathway [24,25]. The CRARF-form of TCF7L2 was shown to interact with two TCF7L2 binding sites within MYC promoter, TBE1 at -1156 bp and TBE2 at -589 bp upstream the first translation start site [13,24]. Therefore, we suggest that while both the CRARF and CRALF forms of TCF7L2 contain E-tails, only the CRARF form regulates MYC expression in the colon. A splicing form detected by assay "ex11-14" is the most common splicing form of TCF7L2 in all human tissues [21,22]. This splicing combination utilizes an alternative stop codon in the beginning of exon 14 resulting in a protein without the CtBP-binding domain. A somatic frameshift mutation in a polyA stretch within exon 14 found in colorectal cancer cell lines results in similar outcome - termination of protein by an alternative stop codon in the beginning of exon 14 [26,27]. We found a moderate correlation between assay "ex11-14" of TCF7L2 and MYC expression (Table 1). Next, we evaluated the levels of mRNA MYC expression in colon tissue in relation to genotypes of rs6983267. We observed significant effect of age, of several TCF7L2 splicing forms but no effect of rs6983267 alone or in interaction with TCF7L2 (Table 2).
###end p 8
###begin p 9
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Detailed structure of C-terminal part of <italic>TCF7L2 </italic>gene</bold>
###xml 54 55 54 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 101 108 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 161 162 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 437 438 437 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 530 532 530 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 609 613 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
Detailed structure of C-terminal part of TCF7L2 gene. A. Combinations of exons 11, 13, 13a and 14 of TCF7L2 encoding proteins with long reading frames (E-tail). B. A form with alternative exon 13 encodes a protein sequence with CRARF motif; a form with alternative exons 13a encodes a protein sequence with CRALF motif, differences in amino acids in proteins encoded by exons 13 and 13a are underlined, CRARF and CRALF motifs are boxed. C. Expression of a splicing form with exon13 correlates with MYC expression (r = 0.60, p < 10-6), while expression of a splicing form with exon 13a does not correlate with MYC expression (r = 0.15, p = 0.12).
###end p 9
###begin p 10
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
Correlation between expression of MYC and TCF7L2 in colon samples
###end p 10
###begin p 11
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
*Spearman correlation coefficient and # two-sided p-values for MYC and TCF7L2 expression in 117 colon samples, p-values are not adjusted for multiple tests
###end p 11
###begin p 12
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
Association of rs6983267 with MYC expression in colon tissue
###end p 12
###begin p 13
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 239 246 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 304 306 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 347 349 347 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
*p-values for univariate regression analysis including 0, 1 and 2 alleles of rs6983267 and expression of MYC assays 1 and 2 in the presence of covariates -- age and level of expression of TCF7L2 assays or interaction between rs6983267 and TCF7L2 expression; p-values are not adjusted for multiple tests; a genotypes were available for 96 samples; b age and genotypes were available for 79 samples.
###end p 13
###begin p 14
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 309 312 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 494 501 491 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 539 541 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 662 666 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 670 676 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1 </italic>
###xml 677 687 674 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyclin D1)</italic>
###xml 688 690 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 732 736 729 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 799 806 796 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 937 944 934 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 958 962 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 1022 1029 1019 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2 </italic>
###xml 1201 1203 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1276 1278 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1621 1625 1618 1622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
Our results show a strong role of TCF7L2 in regulation of MYC expression in colon, but not through rs6983267. Both TCF7L2 and MYC genes are expressed in colon and are important for maintaining proliferation of intestinal epithelium [28,29] (Additional file 3). Inactivation of the adenomatous polyposis coli (APC) tumor suppressor gene leads to formation of beta-catenin/TCF7L2 complexes, constitutive activation of the WNT pathway and eventually colorectal cancer. Rare point mutations within TCF7L2 are also found in colorectal cancers [30]. The proliferative effect of TCF7L2 is achieved through its transcriptional regulation of several target genes such as MYC and CCND1 (Cyclin D1)[31]. Our results suggest that expression of MYC in colon tissue is most likely regulated by a splicing form of TCF7L2 encoding a protein with a potent transactivation CRARF-domain. However, we did not find any evidence for an effect of rs6983267 on TCF7L2 regulation of MYC expression. Of the family of TCF/LEF transcription factors, TCF7L2 has the highest expression in colon, but other members of this family may also be involved. Inactivation of TCF-7 (former TCF-1) leads to development of intestinal polyps [32]. Expression of LEF1 is found in tumors but not in normal colon tissue [33]. Each of these proteins can recognize the same TCF/LEF consensus binding site and, therefore, might bind alleles of rs6983267. High degree of similarity between TCF/LEF proteins may lead to cross-reactivity in chromatin immunoprecipitation (ChIP) assays. Thus, other TCF/LEF factors should also be examined for their effect on regulation of MYC expression.
###end p 14
###begin p 15
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
In conclusion, SNP rs6983267 within the 8q24 region has been established as one of the strongest genetic risk factors for development of at least two types of cancer. Identification of functional mechanisms of this association is the highest priority of cancer genetics and would mean a significant step forward towards understanding of cancer pathogenesis and development of better diagnostic and therapeutic approaches. Our results provide new insights into the regulation of MYC expression by TCF7L2. However, further studies are needed to investigate alternative molecular mechanisms that can explain the association between rs6983267 and cancer risk.
###end p 15
###begin title 16
Competing interests
###end title 16
###begin p 17
The authors declare that they have no competing interests.
###end p 17
###begin title 18
Authors' contributions
###end title 18
###begin p 19
LPO designed and performed the study and wrote manuscript, JLH provided samples and wrote manuscript. Both authors read and approved the final manuscript.
###end p 19
###begin title 20
Supplementary Material
###end title 20
###begin title 21
Additional file 1
###end title 21
###begin p 22
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Materials and methods</bold>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
Materials and methods. The data provided represent the materials, methods and statistical analysis used to study mRNA coexpression of MYC and TCF7L2.
###end p 22
###begin p 23
Click here for file
###end p 23
###begin title 24
Additional file 2
###end title 24
###begin p 25
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression assays used in this study</bold>
Expression assays used in this study. primers, probes and TaqMan assay IDs.
###end p 25
###begin p 26
Click here for file
###end p 26
###begin title 27
Additional file 3
###end title 27
###begin p 28
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Protein expression of MYC and TCF7L2 in normal human colon</bold>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 138 143 <span type="species:ncbi:9606">human</span>
Protein expression of MYC and TCF7L2 in normal human colon. A. Expression of MYC in normal human colon; B. Expression of TCF7L2 in normal human colon. Both proteins show glandular staining in colon epithelium. Images are courtesy of Protein Atlas
###end p 28
###begin p 29
Click here for file
###end p 29
###begin title 30
Acknowledgements
###end title 30
###begin p 31
We thank Yi-Ping Fu for help with statistical analysis. The study was supported by the intramural research program of NCI/NIH (LPO) and by an R21 award to JLH (1R21DK078029-01). We would like to thank Cullan Welch, Nikki Usher, and Marj Carlson for their technical assistance with the tissue processing.
###end p 31
###begin article-title 32
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21
###end article-title 32
###begin article-title 33
A common genetic risk factor for colorectal and prostate cancer
###end article-title 33
###begin article-title 34
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
###end article-title 34
###begin article-title 35
Multiple regions within 8q24 independently affect risk for prostate cancer
###end article-title 35
###begin article-title 36
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24
###end article-title 36
###begin article-title 37
Multiple loci identified in a genome-wide association study of prostate cancer
###end article-title 37
###begin article-title 38
A range of cancers is associated with the rs6983267 marker on chromosome 8
###end article-title 38
###begin article-title 39
Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites
###end article-title 39
###begin article-title 40
Reflecting on 25 years with MYC
###end article-title 40
###begin article-title 41
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
###end article-title 41
###begin article-title 42
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling
###end article-title 42
###begin article-title 43
###xml 56 61 <span type="species:ncbi:9606">human</span>
Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers
###end article-title 43
###begin article-title 44
Identification of c-MYC as a target of the APC pathway
###end article-title 44
###begin article-title 45
Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc
###end article-title 45
###begin article-title 46
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
###end article-title 46
###begin article-title 47
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer
###end article-title 47
###begin article-title 48
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
###end article-title 48
###begin article-title 49
Evaluation of the 8q24 prostate cancer risk locus and MYC expression
###end article-title 49
###begin article-title 50
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling
###end article-title 50
###begin article-title 51
Genetic variation in 8q24 associated with risk of colorectal cancer
###end article-title 51
###begin article-title 52
Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes
###end article-title 52
###begin article-title 53
Tissue-specific alternative splicing of TCF7L2
###end article-title 53
###begin article-title 54
###xml 31 36 <span type="species:ncbi:9606">human</span>
Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas
###end article-title 54
###begin article-title 55
A unique DNA binding domain converts T-cell factors into strong Wnt effectors
###end article-title 55
###begin article-title 56
A new beta-catenin-dependent activation domain in T cell factor
###end article-title 56
###begin article-title 57
TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription
###end article-title 57
###begin article-title 58
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines
###end article-title 58
###begin article-title 59
Myc deletion rescues Apc deficiency in the small intestine
###end article-title 59
###begin article-title 60
###xml 73 77 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
###end article-title 60
###begin article-title 61
###xml 26 31 <span type="species:ncbi:9606">human</span>
The genomic landscapes of human breast and colorectal cancers
###end article-title 61
###begin article-title 62
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
###end article-title 62
###begin article-title 63
Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1
###end article-title 63
###begin article-title 64
Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
###end article-title 64

